Navigation Links
PRA International to Present Audioconference on Oncology Research - Nov. 8
Date:10/23/2007

PRA Oncology Expert to Speak

RESTON, Va., Oct. 23 /PRNewswire-FirstCall/ -- PRA International (Nasdaq: PRAI) today announced that Dr. Ute Berger, the company's senior director of therapeutic expertise and a specialist in oncology and hematology, will present a one-hour audioconference on conducting global clinical research in oncology on Thursday, Nov. 8, 2007 at 11:30 a.m. EST. In "Challenges in Conducting Global Oncology Trials," Dr. Berger will recommend ways to mitigate risk in terms of timelines and costs.

The audioconference will be of special interest to leaders in pharmaceutical and biotechnology research and development, clinical development, operations, clinical studies, outsourcing, procurement, and global data management. The registration fee is US$199 per phone line. For more information and to register, go to http://www.fxtrans.com/resources/ac/future/ac20071108.htm.

The speaker earned her medical degree from Germany's University of Heidelberg where she has served in senior positions on the Faculty of Clinical Medicine for nearly 20 years. Dr. Berger holds medical certifications in internal medicine, oncology and hematology, and is certified by the European Society of Medical Oncology. She has held numerous high-visibility positions, including as medical coordinator for the German CML Study Group, general manager of the German Competence Network "Acute and Chronic Leukemias" and scientific network manager of the "European LeukemiaNet."

Dr. Berger has established relationships with key opinion leaders in the hematology/oncology field around the world. Widely published, she is known for her expertise in clinical research and has significant experience overseeing, directing and implementing global oncology trials in a variety of indications.

The audioconference is presented in cooperation with ForeignExchange Translations, Inc., the leader in providing linguistic services to medical device, pharmaceutical and biotech companies.

About PRA International

PRA International is one of the world's leading global clinical development organizations, with over 2,700 employees working from offices in North America, Europe, Asia, South America, Africa and Australia. PRA is committed to delivering reliable service, program-level therapeutic expertise, easy, global access to knowledge and an involved senior management.

To learn more about PRA International, please visit http://www.prainternational.com or call our World Headquarters at +1 (703) 464-6300.


'/>"/>
SOURCE PRA International
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Olympics of biotechnology has international flavor
2. Traffic data firm navigates international business
3. Catalyst International profit exceeds expectations
4. Lack of broadband hamstrings international videoconferencing
5. 30 days to success: Three simple steps to create your own international startup
6. TEKLYNX International announces new RFID software
7. Ruling enforces international trademark electronic filing requirements
8. Eleftheriou to lead Catalyst International
9. Internet trademark war goes international
10. International eyes drawn to Madisons games research
11. Plexus and SRI International team up to offer medical product development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... Tunnell Consulting, ... Based in Paris, he will focus on acquiring new accounts and work closely ... , “Fred brings to our European clients more than 15 years ...
(Date:2/9/2016)... ... February 09, 2016 , ... PharmApprove announced ... the National Organization for Rare Disorders (NORD). Dorman will lead PharmApprove efforts to ... heard throughout the drug regulatory review process. , “Adding Diane Dorman is just ...
(Date:2/9/2016)... and LONDON , February 9, 2016 ... bio tech replace paper and protect IP ... electronic laboratory notebook (ELN) will be rolled out in ... research and development (R&D) and protect valuable IP. Users will ... follow a specific researcher or experiment as part of the ...
(Date:2/9/2016)... LONDON , Feb. 9, 2016 /PRNewswire/ ... (PTP1B) Inhibitors-Pipeline Insights, 2016", report provides in ... their development activities around the Protein-Tyrosine Phosphatase ... the product profiles in various stages of ... Phase II, Phase III and Preregistration. Report ...
Breaking Biology Technology:
(Date:1/20/2016)... Jan. 20, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce the ... achievements are the result of the company,s laser focus ... eClinical , it,s comprehensive, easy-to-use and highly affordable ... --> Key MedNet growth achievements in 2015 include: ...
(Date:1/18/2016)... 18, 2016  Extenua Inc., a pioneering developer ... use and access of ubiquitous on-premise and cloud ... American Cyber.  ... transformational C4ISR and Cyber initiatives in support of ... proven technology solutions," said Steve Visconti , ...
(Date:1/13/2016)... January 13, 2016 --> ... a new market report titled - Biometric Sensors Market - ... 2015 - 2023. According to the report, the global biometric sensors ... anticipated to reach US$1,625.8 mn by 2023, expanding at ... terms of volume, the biometric sensors market is expected ...
Breaking Biology News(10 mins):